PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)
NCT00515593
·
clinicaltrials.gov ↗
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Postmenopause
Osteoporosis
Interventions
DRUG:
Parathyroid hormone (PTH) (Preotact)
Sponsor
Nycomed